Nanoparticles for use in the redirection against the tumour of a non-tumour-specific immune response, based on a pre-existing immunity

Patent
Publication Date:
2020
Iris type:
6.1 Brevetto
List of contributors:
Authors of the University:
Handle:
https://iris.unipv.it/handle/11571/1343960